A new understanding of how “Frankengene” fusions drive rare, aggressive brain tumors in children is emerging from research at Fred Hutch Cancer Center, offering a potential pathway to targeted therapies for a disease that currently relies heavily on surgery and radiation – treatments with limited efficacy. This breakthrough isn’t just about a single tumor type; … Read more
The seemingly chaotic world of intrinsically disordered proteins (IDPs) just got a little more understandable, with implications for everything from evolutionary biology to the design of future therapeutics. A new study from LMU Munich and collaborating institutions reveals that these crucial, yet structurally flexible, protein regions don’t rely on rigid sequence conservation to maintain function … Read more
Imagine designing a drug not by trial and error, but by predicting its exact impact within a living cell. Or engineering bacteria to consume plastic waste with unparalleled efficiency. These scenarios, once confined to science fiction, are rapidly approaching reality thanks to a groundbreaking achievement: the first complete, 4D simulation of a bacterial cell’s life … Read more